Anexigen Overview
- Year Founded
-
2018
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Anexigen General Information
Description
Developer of novel methods and compositions designed to combat existing and burgeoning antimicrobial threats. The company's platform has the potential to identify novel antibacterial agents with activity against drug-resistant bacteria of biomedical interest and enables functional screening of DNA-encoded peptide-based libraries directly on any Gram-negative pathogen to identify novel antibiotic chemical scaffolds, enabling clinicians and patients to defeat drug-resistant pathogens with its platform and drugs.
Contact Information
Website
www.anexigen.comCorporate Office
- 11099 North Torrey Pines Road
- Suite 290
- La Jolla, CA 92037
- United States
Corporate Office
- 11099 North Torrey Pines Road
- Suite 290
- La Jolla, CA 92037
- United States
Anexigen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Out of Business | 07-Dec-2021 | Completed | Out of Business | |||
| 1. Early Stage VC | 01-Jan-2019 | Completed | Startup |
Anexigen FAQs
-
When was Anexigen founded?
Anexigen was founded in 2018.
-
Where is Anexigen headquartered?
Anexigen is headquartered in La Jolla, CA.
-
What industry is Anexigen in?
Anexigen’s primary industry is Drug Discovery.
-
Is Anexigen a private or public company?
Anexigen is a Private company.
-
What is Anexigen’s current revenue?
The current revenue for Anexigen is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
